Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBS-2004 for Prevention of Travelers' Diarrhea
NCT02736539Phase 3Withdrawn
- Sponsor
- Clasado Biosciences
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Modality
- Microbiome Therapeutics
01
Overview
A Phase 3 trial of galacto-oligosaccharides in traveler's diarrhea (TD), sponsored by Clasado Biosciences. Planned start Apr 2017; status: withdrawn.
02
Drugs
galacto-oligosaccharides
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT02736539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736539.